Proven Efficacy in Both Laboratory Studies
and Real-World Settings
ActivePure is the technology proven to reduce pathogens in the air and on surfaces in real-time.
ActivePure Medical Guardian Testing for Class II Clearance

Bacteria
>99.9999%
Treatment
>99.9999%
Bacteria
>99.999%
>99.99%
>99.99%
>99.993%
New ActivePure Medical Unit Testing
Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage. Gram-positive Bacteria: Staphylococcus Epidermidis. Gram-negative Bacteria: Erwinia Herbicola. Fungal Mold: Apergillus Niger. Bacterial Mold: Bacillus Globigii.

>99.9999%
>99.993%
Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. RNA Virus: MS2 Bacteriophage. DNA Virus: Phi-X174 Bacteriophage.

Bacteria
>99.9999%
Bacteria
>99.999%
Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Gram-positive Bacteria: Staphylococcus Epidermidis. Gram-negative Bacteria: Erwinia Herbicola.

>99.99%
>99.99%
Testing done at Aerosol Research and Engineering Laboratories, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Fungal Mold: Apergillus Niger. Bacterial Mold: Bacillus Globigii.
Candida Auris
Fungus
Reduction of Surface ContaminantsReduction after 48 hours of treatment

ActivePure Induct Unit Testing

ActivePure vs SARS-CoV-2 (The Virus That Causes COVID-19)
Testing completed in August 2020 (surface) and December 2020 (airborne) has shown remarkable levels of reduction in the virus that causes COVID-19.

New Pure & Clean Unit Testing
Testing done at a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates.

Aerus Mid-Range Blaster with ActivePure Technology Unit Testing
Testing was done at MRIGlobal, a 3rd-party unaffiliated laboratory with no connection to ActivePure or its affiliates. Reduction percentages were measured incrementally over natural degradation of SARS-CoV-2. Outside of control group - over 99.9% reduction of the SARS-CoV-2 virus.
ActivePure Is Proven Against a Wide Range of Pathogens
- SARS-CoV-2 (virus)
- Staphylococcus Aureus (Gram+ bacteria)
- Aspergillus Niger (endospore; Toxic Black Mold surrogate)
- H1N1 (Swine Flu; Influenza A virus)
- H5N8 (Bird Flu; Influenza A virus)
- Methicillin-Resistant Staphylococcus Aureus (MRSA; Gram+ bacteria)
- Bacillus Globigii (bacterial endospore; Anthrax surrogate)
- MS2 (RNA bacteriophage virus)
- Staphylococcus Epidermis (Gram+ bacteria)
- Phi-X174 (DNA bacteriophage virus)
- Erwinia Herbicola (Gram- bacteria)
- Listeria Monocytogenes (Gram+ bacteria)
- Murine Norovirus (virus)
- Escherichia Coli (E. Coli; Gram- bacteria)
- Candida Auris (fungus)
- Botrytis Cinerea (fungus)
- Sclerotinia Sclerotiorum (fungus)
- Legionella Pneumophila (Gram- bacteria)
- Aspergillus Versicolor (fungus)
- Clostridioides Difficile (C. Diff; endospore)
- Salmonella Enterica (Gram- bacteria)
- MPX-HUG-2 (Monkeypox; virus)
ActivePure Technology has been proven effective against a broad spectrum of clinically relevant pathogens. Every pathogen has a different level of resistance which is outlined in the hierarchy of pathogens below.
Click here to review our COVID-19 specific test results.

To learn more about the hierarchy of pathogens, review Dr. William Rutala’s Overview of Current Disinfection Hierarchy Models.